- Home
- ISBA vs ENGN Comparison
ISBA vs ENGN Comparison
Compare ISBA & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISBA
- ENGN
- Stock Information
- Founded
- ISBA 1903
- ENGN 1999
- Country
- ISBA United States
- ENGN Canada
- Employees
- ISBA N/A
- ENGN N/A
- Industry
- ISBA
- ENGN
- Sector
- ISBA
- ENGN
- Exchange
- ISBA NYSE
- ENGN Nasdaq
- Market Cap
- ISBA 205.2M
- ENGN 204.3M
- IPO Year
- ISBA N/A
- ENGN N/A
- Fundamental
- Price
- ISBA $38.42
- ENGN $3.15
- Analyst Decision
- ISBA Hold
- ENGN Buy
- Analyst Count
- ISBA 1
- ENGN 7
- Target Price
- ISBA $28.00
- ENGN $23.29
- AVG Volume (30 Days)
- ISBA 32.1K
- ENGN 75.0K
- Earning Date
- ISBA 07-17-2025
- ENGN 06-12-2025
- Dividend Yield
- ISBA 2.79%
- ENGN N/A
- EPS Growth
- ISBA N/A
- ENGN N/A
- EPS
- ISBA 1.97
- ENGN N/A
- Revenue
- ISBA $70,307,000.00
- ENGN N/A
- Revenue This Year
- ISBA $14.17
- ENGN N/A
- Revenue Next Year
- ISBA $7.95
- ENGN N/A
- P/E Ratio
- ISBA $19.50
- ENGN N/A
- Revenue Growth
- ISBA 4.06
- ENGN N/A
- 52 Week Low
- ISBA $17.55
- ENGN $2.65
- 52 Week High
- ISBA $44.99
- ENGN $11.00
- Technical
- Relative Strength Index (RSI)
- ISBA N/A
- ENGN 37.77
- Support Level
- ISBA N/A
- ENGN $3.17
- Resistance Level
- ISBA N/A
- ENGN $3.44
- Average True Range (ATR)
- ISBA 0.00
- ENGN 0.43
- MACD
- ISBA 0.00
- ENGN -0.04
- Stochastic Oscillator
- ISBA 0.00
- ENGN 16.67
About ISBA ISABELLA BANK CORPORATION
Isabella Bank Corp is a U.S based financial service holding company. It offers banking services to businesses, institutions, and individuals. Its lending activities include loans made according to commercial and agricultural operating and real estate purposes, residential real estate loans, and consumer loans. Deposit services offered include checking accounts, savings accounts, certificates of deposit, direct deposits, cash management services, mobile and internet banking, electronic bill pay services and automated teller machines. The company also offers full-service trust and brokerage services.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.